• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Longeveron Inc (NQ: LGVN )

    2.150 -0.100 (-4.44%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Longeveron Inc

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    15 16 Next >
    Peeling Back The Layers: Exploring Longeveron Through Analyst Insights
    Via Benzinga
    Why LENZ Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) to Present ‘Important’ Lomecel-B(TM) Data at the 17th Clinical Trials on Alzheimer’s Disease Conference
    Via Investor Brand Network
    Exposures Product Safety
    BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) to Present at This Month’s Congenital Heart Surgeons’ Society Annual Meeting
    Via Investor Brand Network
    Beyond The Numbers: 4 Analysts Discuss Longeveron Stock
    Via Benzinga
    Longeveron (LGVN) Stock Pops on Phase 2 Trial Updates
    The good news on Lomecel-B comes at an opportune time for Longeveron and LGVN stock -- it could attract a buyer. 
    Via InvestorPlace
    (LGVN) - Analyzing Longeveron's Short Interest
    Via Benzinga
    BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) CEO to Participate in Fireside Cat at UBS Virtual Organ Restoration and Cell Therapy Day
    Via Investor Brand Network
    BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) to Participate at the Cell & Gene Meeting on the Mesa
    Via Investor Brand Network
    Exposures Product Safety
    BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Announces Alignment with FDA on Development Pathway for Lomecel-B(TM) in HLHS
    Via Investor Brand Network
    Exposures Product Safety
    InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Announces Participation at H.C. Wainwright 26th Annual Global Investment Conference
    Via Investor Brand Network
    InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Reports on Q2 2024 Financial Results, Business Highlights
    Via Investor Brand Network
    Exposures Product Safety
    LGVN Stock Earnings: Longeveron Misses EPS, Beats Revenue for Q2 2024
    LGVN stock results show that Longeveron missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Schedules Release of Q2 2024 Financial Results, Earnings Conference Call
    Via Investor Brand Network
    Exposures Product Safety
    EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In July 2024 – Where Do Tesla, Nvidia, Apple, CrowdStrike Rank?
    A look at the most-searched tickers on Benzinga Pro for the month of July shows some familiar names like Tesla, Nvidia and Apple. Here's a look at the others. 
    Via Benzinga
    The Top 3 Small-Cap Stocks to Buy Now: Summer 2024
    Small-cap stocks are on the rise once again as the Federal Reserve ponders cutting interest rates, which has held back the sector. 
    Via InvestorPlace
    Topics Economy
    Exposures Interest Rates
    Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Why Is Cognition Therapeutics (CGTX) Stock Down 33% Today?
    Cognition Therapeutics stock is down on Monday after CGTX investors read the latest data from a Phase 2 clinical trial report. 
    Via InvestorPlace
    BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Lomecel-B(TM) Study Results Presented at the Alzheimer’s Association International Conference
    Via Investor Brand Network
    Exposures Product Safety
    Why Is Alzheimer's-Focused Longeveron Stock Trading Higher On Monday?
    Longeveron presented promising Phase 2a clinical trial data for Lomecel-B at the AAIC 2024. The trial showed the drug's safety and efficacy in treating Alzheimer's, demonstrating slowed disease... 
    Via Benzinga
    Northrop Grumman To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Pre-market stock movers are worth diving into as we check out all of the hottest news affecting shares on Monday morning! 
    Via InvestorPlace
    Why Pitney Bowes Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Closes on $9M Registered Direct Offering
    Via Investor Brand Network
    Exposures Product Safety
    5 Stocks in the News to Watch Now: LGVN, PRSO, SIRI, INBS, VTAK
    Via AB Newswire
    Exposures Product Safety
    Why Longeveron (LGVN) Shares Are Down 15%
    Longeveron shares are trading lower by 15.9% during Thursday's session. The company announced a $9.0 million registered direct offering of 2.2 million shares of its common stock. 
    Via Benzinga
    Why Domino's Pizza Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Expands Growing Telecommunications Sector Through New Subsidiary
    Via Investor Brand Network
    InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Enters into $9M Registered Direct Offering
    Via Investor Brand Network
    Exposures Product Safety
    ACHR Stock Alert: Archer Receives Funding to Expand Manufacturing Facility
    Archer Aviation stock is down on Wednesday as ACHR investors appear unimpressed by plans to expand its manufacturing facility. 
    Via InvestorPlace
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    15 16 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.